Safety and Efficacy of High-Dose Inhaled Nitric Oxide for COVID-19 Viral Pneumonia
Key Findings:
• Intermittent 150-ppm iNO-treatment is well-tolerated, safe, and beneficial compared to usual care for spontaneously breathing hospitalised adults diagnosed with COVID-19 viral pneumonia.
• Oxygen support duration was reduced by 2.7 days, a greater number of subjects reached oxygen saturation ≥ 93% within hospitalisation period, and a trend for earlier discharge was demonstrated.
Practical Solutions and Value:
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians.
Streamlining operations is crucial in today’s healthcare environment. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.
By using AI, clinics can enhance their workflows and improve patient outcomes, reducing paper routine. Learn more about how we can help at aidevmd.com.
